DE3878227D1 - Verfahren zur herstellung eines hochreinen, virusfreien antihaemophiliefaktors mittels chromatographie. - Google Patents

Verfahren zur herstellung eines hochreinen, virusfreien antihaemophiliefaktors mittels chromatographie.

Info

Publication number
DE3878227D1
DE3878227D1 DE8888108458T DE3878227T DE3878227D1 DE 3878227 D1 DE3878227 D1 DE 3878227D1 DE 8888108458 T DE8888108458 T DE 8888108458T DE 3878227 T DE3878227 T DE 3878227T DE 3878227 D1 DE3878227 D1 DE 3878227D1
Authority
DE
Germany
Prior art keywords
antihaemophilia
virus
chromatography
actuator
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE8888108458T
Other languages
German (de)
English (en)
Inventor
Andrew Smith
Myriana Centre Regiona Burnouf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre Regional de Transfusion Sanguine
Original Assignee
Centre Regional de Transfusion Sanguine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8199005&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3878227(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Centre Regional de Transfusion Sanguine filed Critical Centre Regional de Transfusion Sanguine
Application granted granted Critical
Publication of DE3878227D1 publication Critical patent/DE3878227D1/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
DE8888108458T 1988-05-27 1988-05-27 Verfahren zur herstellung eines hochreinen, virusfreien antihaemophiliefaktors mittels chromatographie. Revoked DE3878227D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP88108458A EP0343275B1 (de) 1988-05-27 1988-05-27 Verfahren zur Herstellung eines hochreinen, virusfreien Antihämophiliefaktors mittels Chromatographie

Publications (1)

Publication Number Publication Date
DE3878227D1 true DE3878227D1 (de) 1993-03-18

Family

ID=8199005

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888108458T Revoked DE3878227D1 (de) 1988-05-27 1988-05-27 Verfahren zur herstellung eines hochreinen, virusfreien antihaemophiliefaktors mittels chromatographie.

Country Status (5)

Country Link
EP (1) EP0343275B1 (enExample)
AT (1) ATE85220T1 (enExample)
DE (1) DE3878227D1 (enExample)
ES (1) ES2053619T3 (enExample)
GR (1) GR3007446T3 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0367840B1 (de) 1988-11-05 1993-02-03 Octapharma AG Verfahren zur Herstellung eines hochreinen, nicht infektiösen Antihämophiliefaktors mittels Chromatographie
FR2659557A1 (fr) * 1990-03-15 1991-09-20 Fondation Nale Transfusion San Procede de preparation d'une solution concentree de facteur viii.
FR2665364A1 (fr) * 1990-03-15 1992-02-07 Fond Nale Transfusion Sang Procede de preparation d'une solution concentree de facteur viii.
AT402891B (de) * 1991-06-20 1997-09-25 Immuno Ag Verfahren zur herstellung eines inaktivierten blutproduktes
FR2681867B1 (fr) * 1991-09-26 1993-12-31 Pasteur Merieux Serums Vaccins Procede de purification du facteur viii et preparations obtenues.
DE4204694C3 (de) * 1992-02-01 1995-10-12 Octapharma Ag Verfahren zur Gewinnung von hochreinem, virusinaktiviertem Faktor VIII mittels Anionenaustauscher-Chromatographie
AT399818B (de) * 1992-04-24 1995-07-25 Immuno Ag Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation
EP0674531A1 (de) * 1992-12-16 1995-10-04 IMMUNO Aktiengesellschaft Verfahren zur herstellung eines virussicheren biologischen präparates
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
ES2099678B1 (es) * 1995-11-03 1998-02-16 Grifols Grupo Sa Procedimiento para la inactivacion de virus en proteinas.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4478825A (en) * 1983-10-14 1984-10-23 Armour Pharmaceutical Company Warm ethanol method for preparation of low fibrinogen antihemophilic factor
DE3432083A1 (de) * 1984-08-31 1986-03-06 Behringwerke Ag, 3550 Marburg Pasteurisierte, isoagglutininfreie faktor viii-praeparation und verfahren zu ihrer herstellung
ATE73820T1 (de) * 1986-03-27 1992-04-15 Octapharma Ag Verfahren zur herstellung eines hochgereinigten antihaemophilie-faktors.
US4789545A (en) * 1986-03-31 1988-12-06 New York Blood Center, Inc. Removal of lipid soluble process chemicals from biological materials by extraction with naturally occurring oils or synthetic substitutes thereof

Also Published As

Publication number Publication date
GR3007446T3 (enExample) 1993-07-30
ES2053619T3 (es) 1994-08-01
ATE85220T1 (de) 1993-02-15
EP0343275A1 (de) 1989-11-29
EP0343275B1 (de) 1993-02-03

Similar Documents

Publication Publication Date Title
Johnson et al. Vesicular stomatitis virus and Sindbis virus glycoprotein transport to the cell surface is inhibited by ionophores
Ruoslahti et al. Novel human serum protein from fibroblast plasma membrane
DE69727595D1 (de) Verfahren zur herstellung eines extraktes des plättchenwachstumsfaktors für zubereitungen zur wundheilung
DE69011859D1 (de) Verwendung von sigma-rezeptor-liganden zur herstellung eines anxiolytikums.
DE3587266D1 (de) Verfahren und system zur entfernung von immunosuppressiven bestandteilen aus saeugetierblut.
DK0775150T3 (da) Fremgangsmåde til reduktion eller fjernelse af endotoksiner
DK0869134T3 (da) Fremgangsmåde til udvinding af vækstfaktorer fra mælk eller et mælkederivat
ATE122054T1 (de) Verfahren zur herstellung eines intravenös verträglichen immunglobulin-g-präparates.
FI895447A0 (fi) Substituerade adeninderivat anvaendbara som terapeutiska substanser.
ATE77242T1 (de) Verfahren zur herstellung eines hochreinen, virussicheren, biologisch aktiven transferrinpraeparates.
ATE111480T1 (de) Verfahren zur rückgewinnung rekombinanter proteine unter verwendung von flockungsmitteln.
ES2028913T3 (es) Procedimiento para la fabricacion de una fraccion que contiene el factor viii (ahf).
ATE85220T1 (de) Verfahren zur herstellung eines hochreinen, virusfreien antihaemophiliefaktors mittels chromatographie.
SE7906273L (sv) Sett att framstella en gammaglobulinlosning
ATE80309T1 (de) Verfahren zur herstellung eines konzentrates von alpha-1-antitrypsin von menschlicher plasmafraktion und seine verwendung als arzneimittel.
GB2146027A (en) Process for producing human interferon and method for assaying the interferon productivity of blood
ATE8585T1 (de) Verfahren zur herstellung von blutplasmafraktionen.
ES2049021T3 (es) Metodo de recuperar la proteina epi purificada a partir de una solucion, especialmente una solucion de fermentacion.
SE8101114L (sv) Forfarande for rening av glukosaminoglukaner
DE69510787D1 (de) Verfahren zur herstellung von 1-(3-trialkylsilylphenyl)-2,2,2-trifluoromethyl ethanonderivative
LU90992I2 (fr) Xigris-drotrécogine alfa(activée) et ses dérivés hpharmaceutiquement acceptables
DE3874865D1 (de) 17-halogenmethylen-estratriene.
SU651805A1 (ru) Способ лечени заболеваний роговицы
DE3684459D1 (de) Verfahren zur herstellung eines hochgereinigten antihaemophilie-faktors.
FI873602L (fi) Foerfarande foer inaktivering av vaermesensitiva, patogeniska, i blod existerande virus i igg-preparat.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8331 Complete revocation